Mega Contracts Monitor ($100M+) — June 21, 2026

Leidos Biomedical Research Inc. was awarded a $1.78B contract from the Department of Health and Human Services, indicating strong demand for biodefense and health security capabilities outside traditional DoD channels.

Bollinger Shipyards Lockport, L.L.C. secured a $1.26B contract from the Department of Homeland Security, underscoring sustained investment in maritime border security and Coast Guard fleet modernization.

Both contracts originate from civilian agencies (HHS, DHS) and are classified as defense-related, making them vulnerable to Continuing Resolution (CR) uncertainty if Congress fails to pass full-year appropriations by the start of FY2027.

Pricing risk and competition data are unknown for both contracts, raising concerns about cost overruns (if fixed-price) or margin compression (if cost-plus), particularly for the $1.78B Leidos award.

Leidos Biomedical Research's $1.78B HHS contract positions the firm for follow-on biodefense work as pandemic preparedness and biosecurity remain bipartisan priorities.

Bollinger Shipyards' $1.26B DHS contract signals potential for additional homeland maritime security awards, especially as Coast Guard fleet recapitalization accelerates.

Both contracts, though defense-related, were awarded by civilian agencies (HHS and DHS), indicating a structural shift where non-DoD entities are increasingly executing defense-adjacent missions, particularly in biodefense and maritime security.

{"entity"=>"Leidos Holdings", "reason"=>"Leidos Biomedical Research's $1.78B HHS contract is a significant revenue driver; any option exercises or task order announcements will be material.", "trigger"=>"Task order awards or option exercise dates under the HHS contract"}

{"entity"=>"Bollinger Shipyards", "reason"=>"The $1.26B DHS contract is a major backlog addition; watch for ship delivery milestones and potential follow-on orders.", "trigger"=>"Keel laying or delivery milestones; DHS budget request for FY2027"}